New therapy aims to sharpen Kids' vision and handwriting without drugs
NCT ID NCT07635706
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a 6-week vision-focused occupational therapy program for primary school children aged 8-10 with visual attention issues. Half the children will receive the therapy twice a week, while the other half continue normal school activities. Researchers will measure changes in visual perception, handwriting, and motor skills to see if the program helps.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Visual Skills-Based Occupational Therapy Program
What this could lead to
If it works, this could offer a simple, non-drug way to help children with visual attention issues perform better in school.
What could go wrong
This is a small, early-stage trial with only 32 children, so results may not apply to everyone. The program requires time and effort, and benefits may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VISUAL ATTENTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.